SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+4.85%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$355M
AUM Growth
+$355M
(-14%)
Cap. Flow
-$69.2M
Cap. Flow
% of AUM
-19.49%
Top 10 Holdings %
Top 10 Hldgs %
63.26%
Holding
33
New
3
Increased
9
Reduced
16
Closed
5
Top Buys
| 1 |
Universal Health Services
UHS
|
$12.8M |
| 2 |
CVS Health
CVS
|
$7.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
$6.72M |
| 4 |
Viatris
VTRS
|
$4.99M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$4.81M |
Top Sells
| 1 |
Centene
CNC
|
$15.2M |
| 2 |
Tenet Healthcare
THC
|
$12.2M |
| 3 |
Labcorp
LH
|
$11.5M |
| 4 |
GE HealthCare
GEHC
|
$11.3M |
| 5 |
Biogen
BIIB
|
$9.17M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Medtronic
MDT
$119B
| $35.9M | 10.12% | 411,893 -23,182 | -5% | -$2.02M |
|
2
Pfizer
PFE
$141B
| $34.4M | 9.69% | 1,239,165 +145,749 | +13% | +$4.04M |
|
|
3
Bristol-Myers Squibb
BMY
$96B
| $27M | 7.62% | 498,536 +123,849 | +33% | +$6.72M |
|
|
4
CVS Health
CVS
$92.8B
| $24.6M | 6.92% | 308,004 +89,004 | +41% | +$7.1M |
|
5
Cardinal Health
CAH
$35.5B
| $20.4M | 5.76% | 182,587 +18,282 | +11% | +$2.05M |
|
6
Gilead Sciences
GILD
$140B
| $19.5M | 5.48% | 265,619 -116,743 | -31% | -$8.55M |
|
7
Elevance Health
ELV
$71.8B
| $17.8M | 5.01% | 34,297 +6,490 | +23% | +$3.37M |
|
8
Zimmer Biomet
ZBH
$21B
| $16M | 4.5% | 121,033 -20,185 | -14% | -$2.66M |
|
9
Incyte
INCY
$16.5B
| $15.1M | 4.25% | 264,895 -133,804 | -34% | -$7.62M |
|
10
Baxter International
BAX
$12.7B
| $13.8M | 3.89% | 323,120 -5,012 | -2% | -$214K |
|
|
11
Biogen
BIIB
$19.4B
| $12.9M | 3.63% | 59,698 -42,536 | -42% | -$9.17M |
|
|
12
Universal Health Services
UHS
$11.6B
| $12.8M | 3.59% | +69,881 | New | +$12.8M |
|
13
Bio-Rad Laboratories Class A
BIO
$8.06B
| $11.6M | 3.28% | 33,662 +10,053 | +43% | +$3.48M |
|
|
14
GE HealthCare
GEHC
$33.7B
| $11.2M | 3.16% | 123,133 -124,398 | -50% | -$11.3M |
|
15
Bruker
BRKR
$5.16B
| $10.6M | 2.99% | 112,775 -14,537 | -11% | -$1.37M |
|
16
Edwards Lifesciences
EW
$47.8B
| $10.2M | 2.88% | 106,866 -80,690 | -43% | -$7.71M |
|
|
17
Tenet Healthcare
THC
$16.3B
| $8.15M | 2.3% | 77,535 -115,744 | -60% | -$12.2M |
|
18
Ionis Pharmaceuticals
IONS
$6.79B
| $7.61M | 2.14% | 175,507 +30,495 | +21% | +$1.32M |
|
19
BioMarin Pharmaceuticals
BMRN
$11.2B
| $7.11M | 2% | 81,416 -4,831 | -6% | -$422K |
|
20
Alkermes
ALKS
$4.78B
| $6.83M | 1.93% | 252,319 +52,319 | +26% | +$1.42M |
|
21
Globus Medical
GMED
$8.27B
| $5.65M | 1.59% | 105,381 -128,993 | -55% | -$6.92M |
|
|
22
Viatris
VTRS
$12.3B
| $4.99M | 1.41% | +417,657 | New | +$4.99M |
|
|
23
Agios Pharmaceuticals
AGIO
$2.19B
| $4.81M | 1.35% | +164,378 | New | +$4.81M |
|
24
Qiagen
QGEN
$10.1B
| $4.44M | 1.25% | 103,369 -87,170 | -46% | -$3.75M |
|
25
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.12M | 1.16% | 27,583 -4,509 | -14% | -$674K |
|